HEAL Initiative: Whole Joint Health Program (US)

The National Institutes of Health (NIH), part of the U.S. Department of Health and Human Services, is offering a Notice of Funding Opportunity (NOFO) for the HEAL Initiative: Whole Joint Health Program under funding opportunity number PAR-27-045. This phased mechanistic clinical research program is designed to study biological mechanisms driving joint pain and to test non-pharmacologic or multimodal interventions that directly target those mechanisms. The application deadline is 30 October 2026. Opportunity at a Glance

- Funding opportunity number: PAR-27-045

- Funding opportunity title: HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

- Funding agency: National Institutes of Health (NIH)

- Opportunity type: Grants Notice (Discretionary)

- Funding instrument type: Grant

- Category of funding activity: Health

- Cost sharing or matching requirement: No

- Deadline (applications): 30 October 2026

- Project duration: Phased program up to five years total

- Expected number of awards: Not specified in the source

- Estimated total program funding / award ceiling / award floor: Not specified in the source

About the Opportunity

This NOFO supports a phased mechanistic clinical research program focusing on understudied biological mechanisms that drive joint pain. The funded projects are expected to follow a two-stage approach:

- Phase 1: Identify and validate multi-tissue mechanisms underlying joint pain.

- Phase 2: Test non-pharmacologic or multimodal interventions that directly target the mechanisms identified/validated in Phase 1.

The notice references priorities from the 2023 HEAL Whole Joint Pain Workshop and aligns with broader NIH HEAL Initiative goals, emphasizing safe, non-addictive, prevention-oriented approaches to chronic pain. Funding and Benefits - This is a NIH grant opportunity (Funding Instrument Type: Grant). - No cost sharing or matching is required. - The phased projects are described as up to five years total in duration.

Note: The estimated total program funding, award ceiling, and award floor are not specified in the source.

Who Is Eligible? Eligible applicants (as listed in the source) include the following U.S.-based organizations: - Native American tribal governments (federally recognized) - Native American tribal organizations (other than federally recognized tribal governments) - Independent school districts - Public and State controlled institutions of higher education - Private institutions of higher education - Nonprofits with a 501(c)(3) status with the IRS (other than institutions of higher education) - Nonprofits that do not have a 501(c)(3) status with the IRS (other than institutions of higher education) - Small businesses - For-profit organizations other than small businesses - State governments - City or township governments - County governments - Public housing authorities / Indian housing authorities - Special district governments

- Others: Additional clarification is referenced in the NOFO under “Additional Information on Eligibility.”

Important restrictions on foreign participation

The source states:

- Non-domestic (non-U.S.) entities (foreign organizations) are not eligible to apply. - Non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. - Foreign components (as defined in the NIH Grants Policy Statement) are not allowed. Eligible Activities or Priority Areas The NOFO focuses on joint pain through: - Mechanistic research to identify and validate multi-tissue biological mechanisms driving joint pain. - Testing non-pharmacologic or multimodal interventions that directly target those mechanisms. - The program is described as clinical research and is titled “(R61/R33 Clinical Trial Required)”, indicating that clinical trial requirements apply under the R61/R33 phased structure. (Further specifics are not provided in the supplied source.) Why This Opportunity Matters This opportunity targets a specific gap in chronic pain research by emphasizing understudied biological mechanisms for joint pain and requiring a phased progression from mechanism validation to intervention testing. By focusing on non-pharmacologic or multimodal approaches that directly address identified mechanisms, the program is positioned to support development of prevention-oriented, non-addictive strategies for chronic pain. How to Apply The supplied source page confirms key metadata (opportunity number, deadline, and eligibility) but does not include the full application instructions or submission steps. To apply, you should use the official NIH/Grants.gov instructions linked from the opportunity details. - Review the full Notice of Funding Opportunity (NOFO) for required application components, formatting, and submission requirements. - Prepare your application according to the NOFO requirements, including eligibility confirmations and any clinical trial expectations tied to the R61/R33 structure. - Submit by 30 October 2026. - If you cannot access the full announcement electronically, contact the NIH program officer listed below. Official guidance link Program contact (per source)

- NCCIH Program Officer: [contact details removed]

Application Tips or Common Mistakes - Confirm your organization type matches the source eligibility list and that you meet any additional eligibility clarifications referenced in the NOFO (“Additional Information on Eligibility”). - Ensure your application design aligns with the phased goals: mechanism identification/validation followed by testing non-pharmacologic or multimodal interventions that target those mechanisms. - If your organization includes non-U.S. participation, note that foreign entities/components are not allowed per the source. (Specific selection criteria and document checklists are not included in the supplied text and must be verified in the NOFO.) Frequently Asked Questions

1) What is the funding opportunity number for this NIH HEAL program?

The funding opportunity number is PAR-27-045